Genomic location | Genetic model | rs number (genotypes a vs. b) | Genotype freq. | Metastasis probability | Time-to-metastasis | ||||
---|---|---|---|---|---|---|---|---|---|
OR | 95% CI | p-value | HR | 95% CI | p-value | ||||
22:17793969 | Recessive | rs5749032 (GG vs. AA + AG) | 14% | 0.38 | 0.14–1.07 | 0.066 | 15.86 | 6.83–36.83 | 1.28 × 10−10 |
17:77361176 | Co-Dominant | rs12949587 (CT vs. CC) | 20% | 0.66 | 0.32–1.37 | 0.261 | 7.56 | 3.44–16.61 | 4.63 × 10−7 |
20:15111138 | Co-Dominant | rs6110524 (AG vs. GG) | 17% | 0.95 | 0.44–2.04 | 0.887 | 4.80 | 2.00–11.53 | 4.52 × 10−4 |
7:33913404 | Recessive | rs3815652 (TT vs. CC + CT) | 4% | 0.59 | 0.13–2.65 | 0.488 | 12.97 | 3.26–51.66 | 2.78 × 10−4 |
14:100691178 | Recessive | rs756055 (CC vs. TT + TC) | 13% | 0.28 | 0.10–0.82 | 0.020 | 7.58 | 2.53–22.65 | 2.90 × 10−4 |
14:100730920 | Recessive | rs7153665 (AA vs. GG + AG) | 13% | 0.28 | 0.10–0.82 | 0.020 | 7.58 | 2.53–22.65 | 2.90 × 10−4 |
11:100430053 | Recessive | rs4754687 (AA vs. CC + CA) | 11% | 0.51 | 0.18–1.43 | 0.201 | 8.13 | 2.59–25.53 | 3.28 × 10−4 |
5:155345221 | Dominant | rs2163746 (CT + CC vs. TT) | 24% | 0.49 | 0.23–1.07 | 0.075 | 9.65 | 3.67–25.37 | 4.29 × 10−6 |
5:155361116 | Dominant | rs17053011 (TG + TT vs. GG) | 24% | 0.49 | 0.23–1.07 | 0.075 | 9.65 | 3.67–25.37 | 4.29 × 10−6 |